相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Pyrrole as an Important Scaffold of Anticancer Drugs: Recent Advances
Emilio Mateev et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2022)
Therapeutic potential of pyrrole and pyrrolidine analogs: an update
N. Jeelan Basha et al.
MOLECULAR DIVERSITY (2022)
PLK1 inhibition-based combination therapies for cancer management
Shengqin Su et al.
TRANSLATIONAL ONCOLOGY (2022)
Design, synthesis and biological evaluation of novel 2-phenyl-4,5,6,7-tetrahydro-1H-indole derivatives as potential anticancer agents and tubulin polymerization inhibitors
Guangcheng Wang et al.
ARABIAN JOURNAL OF CHEMISTRY (2022)
Drug Repurposing in Cancer Therapy: Influence of Patient's Genetic Background in Breast Cancer Treatment
Rafaela Rodrigues et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future
Yongwei Qin et al.
INFECTIOUS AGENTS AND CANCER (2022)
Present and Future Perspective on PLK1 Inhibition in Cancer Treatment
Michela Chiappa et al.
FRONTIERS IN ONCOLOGY (2022)
Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis
Javier Cabrera-Sanchez et al.
EUROPEAN RESPIRATORY REVIEW (2022)
An investigation of Plk1 PBD inhibitor KBJK557 as a tumor growth suppressor in non-small cell lung cancer
Pethaiah Gunasekaran et al.
JOURNAL OF ANALYTICAL SCIENCE AND TECHNOLOGY (2022)
Repurposing approved drugs for cancer therapy
Catherine H. Schein
BRITISH MEDICAL BULLETIN (2021)
Cytotoxic Effect of Bromelain on HepG2 Hepatocellular Carcinoma Cell Line
Sushma S. Murthy et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2021)
Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes
Vineela Parvathaneni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Crosstalk between Plk1, p53, cell cycle, and G2/M DNA damage checkpoint regulation in cancer: computational modeling and analysis
Yongwoon Jung et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2021)
Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC)
Suyash M. Patil et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
Alan Talevi et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Discovery of Targeted Covalent Natural Products against PLK1 by Herb-Based Screening
Hao Liang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors
Nashwa M. Saleh et al.
FRONTIERS IN CHEMISTRY (2020)
Eriodictyol exerts potent anticancer activity against A549 human lung cancer cell line by inducing mitochondrial-mediated apoptosis, G2/M cell cycle arrest and inhibition of m-TOR/PI3K/Akt signalling pathway
Yong Zhang et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
Molecular and enzoinformatics perspectives of targeting Polo-like kinase 1 in cancer therapy
Shazi Shakil et al.
SEMINARS IN CANCER BIOLOGY (2019)
An oncoinformatics study to predict the inhibitory potential of recent FDA-approved anti-cancer drugs against human Polo-like kinase 1 enzyme: a step towards dual-target cancer medication
Syed Mohd. Danish Rizvi et al.
3 BIOTECH (2019)
Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents
H. A. Arjun et al.
FRONTIERS IN CHEMISTRY (2019)
Repurposing antitubercular agent isoniazid for treatment of prostate cancer
Qingzhi Lv et al.
BIOMATERIALS SCIENCE (2019)
3-Chloro-N′-(2-hydroxybenzylidene)benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
Federica Sarno et al.
FRONTIERS IN PHARMACOLOGY (2018)
Novel glitazones as PPAR agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies
Subhankar P. Mandal et al.
CHEMISTRY CENTRAL JOURNAL (2018)
Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors
Shrinivas D. Joshi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
New Tripentone Analogs with Antiproliferative Activity
Barbara Parrino et al.
MOLECULES (2017)
Review: biologically active pyrazole derivatives
Anam Ansari et al.
NEW JOURNAL OF CHEMISTRY (2017)
PLK1, A Potential Target for Cancer Therapy
Zhixian Liu et al.
TRANSLATIONAL ONCOLOGY (2017)
Target β-catenin/CD44/Nanog axis in colon cancer cells by certain N′-(2-oxoindolin-3-ylidene)-2-(benzyloxy)benzohydrazides
Awwad A. Radwan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
N′-((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)benzohydrazide as a probable Bcl-2/Bcl-xL inhibitor with apoptotic and anti-metastatic potential
Pooja R. Kamath et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
Rosie Elizabeth Ann Gutteridge et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Design, Synthesis and Biological Evaluation of Benzohydrazide Derivatives Containing Dihydropyrazoles as Potential EGFR Kinase Inhibitors
Hai-Chao Wang et al.
MOLECULES (2016)
A novel anti-microtubule agent with carbazole and benzohydrazide structures suppresses tumor cell growth in vivo
Makoto Ohira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Analogues of ethionamide, a drug used for multidrug-resistant tuberculosis, exhibit potent inhibition of tyrosinase
Joonhyeok Choi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors
Joonhyeok Choi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone
Dennis Falzon et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2014)
Medicinal attributes of pyrazolo[3,4-d]pyrimidines: A review
Monika Chauhan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence?
Brian D. Cholewa et al.
CANCER RESEARCH (2013)
SwissParam: A Fast Force Field Generation Tool for Small Organic Molecules
Vincent Zoete et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Open Babel: An open chemical toolbox
Noel M. O'Boyle et al.
JOURNAL OF CHEMINFORMATICS (2011)
Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small-Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis in Human Melanoma Cells
Travis L. Schmit et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
Berk Hess et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
Structure of the catalytic domain of human polo-like kinase 1
Michael Kothe et al.
BIOCHEMISTRY (2007)
Synthesis and structure-activity relationships of a series of pyrrole cannabinoid receptor agonists
G Tarzia et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K
P Mark et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2001)